SPEL Semiconductor Fund Raise of ₹1,000 Cr

SPEL Semiconductor Management Change

Independent Director Mr. Ramanujam Venkatesh has resigned from the Board of SPEL Semiconductor Limited, effective October 16, 2026, citing personal reasons.

SPEL Semiconductor Other Announcement

SPEL Semiconductor Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.

SPEL Semiconductor Annual General Meeting

SPEL Semiconductor Ltd held its 41st Annual General Meeting on September 14, 2026, via video conferencing to transact business as per the notice.

SPEL Semiconductor Annual General Meeting

SPEL Semiconductor filed its Annual Report for FY 2025-26. The company also announced its 41st Annual General Meeting scheduled for September 14, 2026.

SPEL Semiconductor Board Meeting Outcome

SPEL Semiconductor approved its unaudited financial results for the quarter ended June 30, 2026. The company also scheduled its 41st Annual General Meeting for September 14, 2026.

SPEL Semiconductor Q1 FY27 Results: Net Loss of ₹13.4 Cr, Loss Widens

SPEL Semiconductor Ltd reported revenue from operations of ₹0.1 Cr (-94.7% YoY) and a net loss of ₹13.4 Cr for Q1 FY27.

Key figure

Net loss ₹13.4 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.

Gujarat Inject (Kerala) Fund Raise of ₹3 Cr

Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.

Value

₹3.00 Cr